ValuEngine upgraded shares of Semler Scientific (OTCMKTS:SMLR) from a sell rating to a hold rating in a research note released on Saturday, ValuEngine reports.

SMLR stock traded up $0.05 during mid-day trading on Friday, reaching $43.55. The company had a trading volume of 2,974 shares, compared to its average volume of 17,264. The company has a market capitalization of $283.96 million, a price-to-earnings ratio of 65.98, a price-to-earnings-growth ratio of 1.55 and a beta of 0.38. The firm has a fifty day simple moving average of $41.79 and a 200 day simple moving average of $44.38. Semler Scientific has a fifty-two week low of $25.50 and a fifty-two week high of $54.50.

Semler Scientific (OTCMKTS:SMLR) last posted its quarterly earnings results on Friday, July 26th. The medical equipment provider reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.10. Semler Scientific had a return on equity of 155.19% and a net margin of 27.91%. The company had revenue of $7.95 million for the quarter, compared to analyst estimates of $6.72 million. Sell-side analysts predict that Semler Scientific will post 1.13 EPS for the current year.

In other news, Director Wayne T. Pan sold 600 shares of the firm’s stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $51.16, for a total transaction of $30,696.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 14.10% of the stock is currently owned by company insiders.

Semler Scientific Company Profile

Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Featured Story: Margin

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with's FREE daily email newsletter.